Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes

DSpace Repository

Show simple item record

dc.contributor.author Birkenfeld, Andreas L.
dc.date.accessioned 2021-07-13T06:28:48Z
dc.date.available 2021-07-13T06:28:48Z
dc.date.issued 2020
dc.identifier.issn 2045-2322
dc.identifier.uri http://hdl.handle.net/10900/117073
dc.language.iso en de_DE
dc.publisher Nature Research de_DE
dc.relation.uri http://dx.doi.org/10.1038/s41598-020-78734-z de_DE
dc.subject.ddc 500 de_DE
dc.title Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes de_DE
dc.type Article de_DE
utue.quellen.id 20210304112512_00027
utue.personen.roh Aberle, Jens
utue.personen.roh Menzen, Markus
utue.personen.roh Schmid, Sebastian M.
utue.personen.roh Terkamp, Christoph
utue.personen.roh Jaeckel, Elmar
utue.personen.roh Rohwedder, Katja
utue.personen.roh Scheerer, Markus F.
utue.personen.roh Xu, John
utue.personen.roh Tang, Weifeng
utue.personen.roh Birkenfeld, Andreas L.
dcterms.isPartOf.ZSTitelID Scientific Reports de_DE
dcterms.isPartOf.ZS-Issue Article 22396 de_DE
dcterms.isPartOf.ZS-Volume 10 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record